| NCBI/Ensembl Id | Dosage & Time point | Experiment Type | Cell line | lncRNA name as in article | Expression | Fold change | P-value | Differential expression quantification method | Statistical method | Year | PubMed ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MAMDC2-AS1 | MOI = 3 ; 12 hr |
qPCR | HaCaT (CRL-2310) Human epidermis keratinocyte cells | MAMDC2-AS1 | Upregulation | 6 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 3 ; 12 hr |
qPCR | HaCaT (CRL-2310) Human epidermis keratinocyte cells | MAMDC2-AS1 | Upregulation | 6 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 3 ; 12 hr |
qPCR | HeLa Human papillomavirus-related endocervical adenocarcinoma cells | MAMDC2-AS1 | Upregulation | 8 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 3 ; 12 hr |
qPCR | A-549 Human adenocarcinomic alveolar basal epithelial cells | MAMDC2-AS1 | Upregulation | 4 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 3 ; 12 hr |
qPCR | HepG2 Human Hepatoblastoma | MAMDC2-AS1 | Upregulation | 7.9 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 3 ; 12 hr |
qPCR | Human foreskin fibroblasts (HFF) | MAMDC2-AS1 | Upregulation | 7 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 0.5; 12 hr |
qPCR | HaCaT (CRL-2310) Human epidermis keratinocyte cells | MAMDC2-AS1 | Upregulation | 3 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 1 ; 12 hr |
qPCR | HaCaT (CRL-2310) Human epidermis keratinocyte cells | MAMDC2-AS1 | Upregulation | 4.2 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 2 ; 12 hr |
qPCR | HaCaT (CRL-2310) Human epidermis keratinocyte cells | MAMDC2-AS1 | Upregulation | 5 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 3 ; 12 hr |
qPCR | HaCaT (CRL-2310) Human epidermis keratinocyte cells | MAMDC2-AS1 | Upregulation | 6 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 5 ; 12 hr |
qPCR | HaCaT (CRL-2310) Human epidermis keratinocyte cells | MAMDC2-AS1 | Upregulation | 10 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 0.5; 12 hr |
qPCR | HeLa Human papillomavirus-related endocervical adenocarcinoma cells | MAMDC2-AS1 | Upregulation | 5 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 1 ; 12 hr |
qPCR | HeLa Human papillomavirus-related endocervical adenocarcinoma cells | MAMDC2-AS1 | Upregulation | 6 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 2 ; 12 hr |
qPCR | HeLa Human papillomavirus-related endocervical adenocarcinoma cells | MAMDC2-AS1 | Upregulation | 6.2 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 3 ; 12 hr |
qPCR | HeLa Human papillomavirus-related endocervical adenocarcinoma cells | MAMDC2-AS1 | Upregulation | 7.5 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 5 ; 12 hr |
qPCR | HeLa Human papillomavirus-related endocervical adenocarcinoma cells | MAMDC2-AS1 | Upregulation | >10 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 3; 2 hr |
qPCR | HaCaT (CRL-2310) Human epidermis keratinocyte cells | MAMDC2-AS1 | Upregulation | >2 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 3; 4 hr |
qPCR | HaCaT (CRL-2310) Human epidermis keratinocyte cells | MAMDC2-AS1 | Upregulation | >2 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 3; 6 hr |
qPCR | HaCaT (CRL-2310) Human epidermis keratinocyte cells | MAMDC2-AS1 | Upregulation | >2 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 3; 8 hr |
qPCR | HaCaT (CRL-2310) Human epidermis keratinocyte cells | MAMDC2-AS1 | Upregulation | 4 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 3; 12 hr |
qPCR | HaCaT (CRL-2310) Human epidermis keratinocyte cells | MAMDC2-AS1 | Upregulation | >4 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 3; 2 hr |
qPCR | HeLa Human papillomavirus-related endocervical adenocarcinoma cells | MAMDC2-AS1 | Upregulation | >2 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 3; 4 hr |
qPCR | HeLa Human papillomavirus-related endocervical adenocarcinoma cells | MAMDC2-AS1 | Upregulation | 4 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 3; 6 hr |
qPCR | HeLa Human papillomavirus-related endocervical adenocarcinoma cells | MAMDC2-AS1 | Upregulation | >4 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 3; 8 hr |
qPCR | HeLa Human papillomavirus-related endocervical adenocarcinoma cells | MAMDC2-AS1 | Upregulation | 6 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 3; 12 hr |
qPCR | HeLa Human papillomavirus-related endocervical adenocarcinoma cells | MAMDC2-AS1 | Upregulation | 8 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 3 ; 12 hr |
qPCR | HaCaT (CRL-2310) Human epidermis keratinocyte cells | MAMDC2-AS1 | Upregulation | 6 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 3 ; 12 hr |
qPCR | HeLa Human papillomavirus-related endocervical adenocarcinoma cells | MAMDC2-AS1 | Upregulation | 8 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 3 ; 12 hr |
qPCR | A-549 Human adenocarcinomic alveolar basal epithelial cells | MAMDC2-AS1 | Upregulation | 4 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 3 ; 12 hr |
qPCR | HepG2-4D14 Human hepatoma cells | MAMDC2-AS1 | Upregulation | 7.8 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 3 ; 12 hr |
qPCR | Human foreskin fibroblasts(HFF) | MAMDC2-AS1 | Upregulation | 7 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 0.5 ; 12 hr |
qPCR | HaCaT (CRL-2310) Human epidermis keratinocyte cells | MAMDC2-AS1 | Upregulation | 3 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 1 ; 12 hr |
qPCR | HaCaT (CRL-2310) Human epidermis keratinocyte cells | MAMDC2-AS1 | Upregulation | 4.9 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 3 ; 12 hr |
qPCR | HaCaT (CRL-2310) Human epidermis keratinocyte cells | MAMDC2-AS1 | Upregulation | 7 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 0.5 ; 12 hr |
qPCR | HeLa Human papillomavirus-related endocervical adenocarcinoma cells | MAMDC2-AS1 | Upregulation | 5 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 2 ; 12 hr |
qPCR | HeLa Human papillomavirus-related endocervical adenocarcinoma cells | MAMDC2-AS1 | Upregulation | 6 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 3 ; 2 hr |
qPCR | HaCaT (CRL-2310) Human epidermis keratinocyte cells | MAMDC2-AS1 | Upregulation | 2.4 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 3 ; 4 hr |
qPCR | HaCaT (CRL-2310) Human epidermis keratinocyte cells | MAMDC2-AS1 | Upregulation | 2.5 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 3 ; 6 hr |
qPCR | HaCaT (CRL-2310) Human epidermis keratinocyte cells | MAMDC2-AS1 | Upregulation | 3.8 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 3 ; 8 hr |
qPCR | HaCaT (CRL-2310) Human epidermis keratinocyte cells | MAMDC2-AS1 | Upregulation | 4.2 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 3 ; 12 hr |
qPCR | HaCaT (CRL-2310) Human epidermis keratinocyte cells | MAMDC2-AS1 | Upregulation | 5.8 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 3 ; 2 hr |
qPCR | HeLa Human papillomavirus-related endocervical adenocarcinoma cells | MAMDC2-AS1 | Upregulation | 2.4 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 3 ; 4 hr |
qPCR | HeLa Human papillomavirus-related endocervical adenocarcinoma cells | MAMDC2-AS1 | Upregulation | 4 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 3 ; 6 hr |
qPCR | HeLa Human papillomavirus-related endocervical adenocarcinoma cells | MAMDC2-AS1 | Upregulation | 5 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 3 ; 8 hr |
qPCR | HeLa Human papillomavirus-related endocervical adenocarcinoma cells | MAMDC2-AS1 | Upregulation | 5.9 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| MAMDC2-AS1 | MOI = 3 ; 12 hr |
qPCR | HeLa Human papillomavirus-related endocervical adenocarcinoma cells | MAMDC2-AS1 | Upregulation | 8 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 | |
| SMC5-DT | MOI = 3 ; 12 hr |
qPCR | HaCaT (CRL-2310) Human epidermis keratinocyte cells | MAMDC2-AS2 | Upregulation | 7 | p < 0.01 | student's two-tailed t test | 2020 | 32226304 |
* MOI :Multiplicity of infection , TCID :Tissue Culture Infectious Dose